TCF7L2 rs601491: Understanding Your Genetic Predisposition
The rs601491 variant is a specific genetic marker located within the TCF7L2 gene. It is widely recognized in genomic research for its statistical association with altered pancreatic beta-cell function and an increased predisposition to type 2 diabetes.
What each genotype means
Typical risk profile
You carry two copies of the common C allele for this marker. In genetic association studies, this baseline genotype is not associated with elevated genetic susceptibility to type 2 diabetes or impaired beta-cell insulin secretion. However, overall diabetes risk remains strongly influenced by lifestyle, diet, and other genetic factors.
Carried by approximately 50% to 55% of individuals of European and South Asian ancestry, and more prevalent in East Asian populations.
Slightly increased diabetes predisposition
You carry one copy of the T risk allele at rs601491 in the TCF7L2 gene. Studies show a modest statistical association between this genotype and reduced pancreatic beta-cell function along with a slightly increased predisposition to type 2 diabetes. Because the overall scientific evidence for this specific variant is limited, carrying this allele does not mean you will develop diabetes.
Carried by roughly 35% to 42% of individuals in European and South Asian populations.
Increased diabetes predisposition
You carry two copies of the T risk allele for this TCF7L2 variant. In observational research, homozygous carriers show a statistical correlation with reduced insulin secretion and a higher relative predisposition to type 2 diabetes compared to non-carriers. Given that individual variants confer modest effects and evidence for this marker is limited, lifestyle measures remain primary determinants of metabolic health.
Carried by approximately 6% to 9% of people in European and South Asian ancestral groups.
What is the rs601491 Variant?
The rs601491 variant is a single nucleotide polymorphism (SNP) found within the TCF7L2 gene, which stands for Transcription Factor 7-Like 2. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is located in a region of the genome that has been extensively studied due to its strong link to metabolic health. When researchers analyze large populations, they look for these markers to understand why some individuals may have a higher statistical likelihood of developing certain conditions. It is important to note that rs601491 is just one of many variations within this gene, and its presence does not guarantee the development of any health condition. Instead, it serves as a piece of data that contributes to our broader understanding of the complex genetic architecture underlying human metabolism and glucose regulation.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for making a protein that acts as a transcription factor, a type of protein that helps control the activity of other genes. This protein plays a critical role in the Wnt signaling pathway, which is essential for various developmental processes, including the maintenance and function of pancreatic beta-cells. Beta-cells are specialized cells in the pancreas responsible for producing and secreting insulin, the hormone that regulates blood glucose levels. Research suggests that variations in TCF7L2 may influence how these cells process proinsulin or respond to glucose signals. By modulating these pathways, the gene influences the body's ability to maintain stable blood sugar levels. Because of its central role in insulin secretion, TCF7L2 is considered one of the most significant genetic loci identified to date in relation to the risk of developing type 2 diabetes across diverse human populations.
Research and Evidence Strength
The association between TCF7L2 variants and type 2 diabetes is supported by a substantial body of genomic research, including large-scale genome-wide association studies (GWAS). While the evidence linking TCF7L2 to diabetes risk is robust and reproducible, the specific functional impact of individual SNPs like rs601491 is often categorized as having limited or moderate direct evidence compared to the gene's overall impact. Studies have observed that certain alleles are linked to impaired insulin secretion and altered glucose tolerance. However, it is crucial to understand that these findings are statistical associations observed in large groups of people, not direct causal mechanisms for every individual. The influence of this variant can also be modified by environmental factors, such as diet, physical activity, and overall lifestyle. Because the biological pathways are complex, scientists continue to investigate how these genetic markers interact with other genes and external triggers to influence metabolic health outcomes.
What You Can Do With This Information
Learning about your genetic variants can be an educational experience, but it is important to maintain a balanced perspective. Genetic information regarding TCF7L2 is intended for informational purposes and should not be used to diagnose or predict personal health outcomes. Because type 2 diabetes is a multifactorial condition influenced by both genetics and lifestyle, knowing your genotype does not replace the need for regular medical check-ups. If you are concerned about your metabolic health or diabetes risk, the most effective step is to consult with a healthcare professional. They can evaluate your family history, blood glucose levels, and other clinical markers to provide personalized guidance. Never make changes to your diet, exercise routine, or medical treatment based solely on genetic test results without first discussing them with your doctor or a qualified healthcare provider. Your clinician can help you interpret this information within the context of your overall health profile.
How common is this variant?
The minor allele frequency for variants in this region typically ranges from 0.25 to 0.30 in European and South Asian populations, though frequencies can vary significantly across different global ancestries.
Frequently asked questions
Does having the TCF7L2 risk variant mean I will get diabetes?
No, having a specific genotype does not mean you will develop diabetes. Genetic variants only represent a statistical increase in risk, and many people with the variant never develop the condition.
Can I change my genetic risk for diabetes?
You cannot change your DNA, but you can influence how your genes affect your health through lifestyle choices. Maintaining a healthy diet and regular physical activity are known to help manage metabolic health regardless of your genetic background.
Should I get tested for TCF7L2 variants?
Genetic testing for common variants like rs601491 is generally not recommended for clinical diagnosis. If you are worried about diabetes, standard clinical tests like fasting glucose or HbA1c are much more informative for your current health status.
Is TCF7L2 the only gene linked to diabetes?
No, type 2 diabetes is a complex condition influenced by hundreds of different genetic variants. TCF7L2 is simply one of the most well-studied and statistically significant markers identified by researchers.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs601491?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.
This variant is one of the strongest genetic risk factors for Type 2 diabetes, affecting insulin secretion.